The Centers for Medicare & Medicaid Services finalized its Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System rule for fiscal 2027, introducing a 2.3% standard payment update for acute care and long-term care facilities alongside a major expansion of mandatory value-based care models, according to an agency news release issued on July 31.
The sweeping federal regulation, spanning thousands of pages, recalibrates financial baselines for hospitals nationwide while reshaping quality metrics and technology reimbursement pathways. CMS Administrator Mehmet Oz, MD, emphasized in the July 31 announcement that the changes are designed to align federal reimbursement with measurable clinical outcomes.
“Knee, hip, and ankle replacements are important for helping seniors preserve their mobility and overall well-being,” Dr. Oz stated in the release. “Expanding the joint replacement pilot program to support more of our seniors will help match financial incentives in Medicare with improved health outcomes, safeguard taxpayer resources and ensure patients experience a positive, comprehensive care journey throughout the surgical process.”
Fiscal 2027 Inpatient Payment Updates and Financial Impact
Acute care hospitals meeting specific federal reporting standards will receive a 2.3% payment rate update for fiscal 2027. This final figure reflects a 3.2% market basket increase offset by a 0.9 percentage point productivity adjustment. The updated rate lands just below the 2.4% adjustment originally floated by federal regulators in April, which included a slightly lower 0.8 percentage point productivity cut.
To qualify for the full 2.3% rate update, hospitals must satisfy mandatory Hospital Inpatient Quality Reporting requirements and demonstrate meaningful use of electronic health record systems. Long-term care hospitals will receive an identical 2.3% standard rate update, resulting in an estimated payment increase of roughly 2.2%, or approximately $54 million.
Across the entire acute care sector, CMS estimates that the combined policy changes will increase total inpatient payments by roughly $2.1 billion in fiscal 2027. This total significantly exceeds the $1.4 billion projection initially outlined in the proposed rule earlier in the year.
Mandatory Nationwide Joint Replacement Model Expansion
A central pillar of the new rule is the finalization of the Comprehensive Care for Joint Replacement Expanded model, known as CJR-X. This initiative represents the first mandatory, nationwide episode-based payment model implemented by the federal health agency.
The implementation date for CJR-X is scheduled for January 1, 2028, pushed back from the initial October 1, 2027 target date proposed in April. Under the model, most Inpatient Prospective Payment System hospitals will bear financial accountability for total Medicare spending associated with hip, knee, and ankle replacements. The episode of care covers the surgical procedure, the inpatient hospitalization, and the first 90 days of post-acute recovery.
The expanded program builds upon the original Comprehensive Care for Joint Replacement model, which operated from April 2016 through December 2024. According to federal evaluations, the predecessor program saved Medicare more than $100 million while maintaining clinical quality standards. Hospitals already participating in the Transforming Episode Accountability Model, facilities located in Maryland, and institutions not reimbursed under both inpatient and outpatient prospective payment systems may qualify for exemptions.
Quality Measures, Sepsis Tracking, and Medicare Advantage Data Integration
The fiscal 2027 rule incorporates significant adjustments to how patient data influences hospital quality scoring and reimbursement. CMS is officially integrating Medicare Advantage claims data into several core federal evaluation programs, including the Inpatient Quality Reporting, Value-Based Purchasing, and Readmissions Reduction programs. Performance periods across these metrics are being shortened from three years to two years.
Federal officials tied this methodological shift to the expanding market share of private Medicare plans, which now cover more than half of all Medicare beneficiaries—totaling roughly 35 million individuals. The integration directly impacts risk-standardized mortality measures for common conditions, including heart attacks, heart failure, pneumonia, chronic obstructive pulmonary disease, and coronary artery bypass graft surgeries.
In addition to mortality tracking, the rule establishes a 30-day, risk-standardized sepsis readmission measure within the Hospital Readmissions Reduction Program. Affected hospitals will receive two years of confidential early-look reports during the fiscal 2028 and 2029 program cycles. The sepsis metric will officially factor into payment penalty calculations beginning in fiscal 2030.
Technology Add-On Payments and Interoperability Mandates
Reimbursement for breakthrough medical innovations is slated to increase substantially. CMS projects that new technology add-on payments will rise to approximately $779 million in fiscal 2027, marking a sharp increase from the $464 million estimated in the proposed rule due to a higher volume of product approvals.
Concurrently, the Medicare Promoting Interoperability Program introduces new technology benchmarks. Electronic prior authorization measures will debut as an optional bonus in 2027 before becoming fully mandatory in 2028. The agency has also incorporated a unique device identifier measure for implantable medical devices, aligned facility certification criteria with recent federal health IT proposals, and updated electronic clinical quality measures.
Furthermore, graduate medical residency programs, along with approved nursing and allied health education programs, face new federal nondiscrimination mandates. The finalized provisions prohibit approved programs from discriminating—or encouraging discrimination—based on race, color, national origin, sex, age, disability, or religion, explicitly barring the use of those characteristics or intentional proxies as selection criteria in medical education.
Stakeholders and healthcare administrators can review the complete regulatory text through the official federal registry and the CMS portal.